BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19682619)

  • 1. Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies?
    Leonardi S; Spina M; Spicuzza L; Rotolo N; La Rosa M
    Vaccine; 2009 Oct; 27(43):6030-3. PubMed ID: 19682619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease.
    Nemes E; Lefler E; Szegedi L; Kapitány A; Kovács JB; Balogh M; Szabados K; Tumpek J; Sipka S; Korponay-Szabó IR
    Pediatrics; 2008 Jun; 121(6):e1570-6. PubMed ID: 18519462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response to hepatitis B vaccine: does it differ in celiac disease?
    Ertem D; Gonen I; Tanidir C; Ugras M; Yildiz A; Pehlivanoğlu E; Eksioglu-Demiralp E
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):787-93. PubMed ID: 19584738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to respond to hepatitis B vaccine in children with celiac disease.
    Park SD; Markowitz J; Pettei M; Weinstein T; Sison CP; Swiss SR; Levine J
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):431-5. PubMed ID: 17414139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccine nonresponse and celiac disease.
    Noh KW; Poland GA; Murray JA
    Am J Gastroenterol; 2003 Oct; 98(10):2289-92. PubMed ID: 14572581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal or defective immune response to Hepatitis B vaccine in patients with diabetes and celiac disease.
    Zanoni G; Contreas G; Valletta E; Gabrielli O; Mengoli C; Veneri D
    Hum Vaccin Immunother; 2015; 11(1):58-62. PubMed ID: 25483516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunogenicity of a recombinant vaccine against viral hepatitis B].
    Russo R; Ripa F; Ditommaso S; Zotti C; Moiraghi Ruggenini A
    Ann Ist Super Sanita; 1992; 28(4):563-7. PubMed ID: 1303051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HLA phenotype with primary non-response to recombinant hepatitis B vaccine: a study from north India.
    Das K; Gupta RK; Kumar V; Singh S; Kar P
    Trop Gastroenterol; 2004; 25(3):113-5. PubMed ID: 15682656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination scheme in advanced chronic kidney disease].
    Barril G; Teruel JL
    Nefrologia; 2008; 28 Suppl 3():95-9. PubMed ID: 19018745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccination and celiac disease: results of a retrospective study].
    Leonardi S; Longo R; Cotugno M; Tardino L; Spina M; Lionetti E; La Rosa M
    Minerva Pediatr; 2011 Oct; 63(5):363-7. PubMed ID: 21946447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to a vaccination schedule with 4 doses of 40 microg against hepatitis B virus in cirrhotic patients evaluated for liver transplantation.
    Pascasio JM; Aoufi S; Gash A; Sousa JM; Perea R; Sayago M; Ferrer MT; Valencia R; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2943-5. PubMed ID: 19010154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to hepatitis B vaccination in patients with celiac disease.
    Ahishali E; Boztas G; Akyuz F; Ibrisim D; Poturoglu S; Pinarbasi B; Ozdil S; Mungan Z
    Dig Dis Sci; 2008 Aug; 53(8):2156-9. PubMed ID: 18157638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DRB1, DQA1 and DQB1 alleles and haplotypes frequencies in Iranian healthy adult responders and non-responders to recombinant hepatitis B vaccine.
    Amirzargar AA; Mohseni N; Shokrgozar MA; Arjang Z; Ahmadi N; Yousefi Behzadi M; Amanzadeh A; Shokri F
    Iran J Immunol; 2008 Jun; 5(2):92-9. PubMed ID: 18523354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
    Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
    Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B vaccination in haemodialysis patients: a randomized clinical trial.
    Bock M; Barros E; Veronese FJ
    Nephrology (Carlton); 2009 Apr; 14(3):267-72. PubMed ID: 19207871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect.
    Vermeulen BA; Hogen Esch CE; Yuksel Z; Koning F; Verduijn W; Doxiadis II; Schreuder GM; Mearin ML
    Scand J Gastroenterol; 2009; 44(1):40-5. PubMed ID: 18932050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal determination of hepatitis B surface antigen-specific B lymphocyte frequency in healthy high responder adults after booster vaccination.
    Sam MR; Shokrgozar MA; Shokri F
    Intervirology; 2008; 51(2):87-95. PubMed ID: 18477849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigens in Turkish pediatric celiac patients.
    Erkan T; Kutlu T; Yilmaz E; Cullu F; Tümay GT
    Turk J Pediatr; 1999; 41(2):181-8. PubMed ID: 10770656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does efficient haemodialysis improve the response to hepatitis B virus vaccination?].
    Kovacić V; Sain M; Vukman V
    Lijec Vjesn; 2004; 126(5-6):133-7. PubMed ID: 15628681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.